[HTML][HTML] How infection and vaccination are linked to acute and chronic urticaria: a special focus on COVID-19

E Kocatürk, M Muñoz, D Elieh-Ali-Komi, PR Criado… - Viruses, 2023 - mdpi.com
Since more than a century ago, there has been awareness of the connection between viral
infections and the onset and exacerbation of urticaria. Our knowledge about the role of viral …

Impact of anti-type 2 inflammation biologic therapy on COVID-19 clinical course and outcome

D Poddighe, E Kovzel - Journal of inflammation research, 2021 - Taylor & Francis
SARS-CoV-2 pandemic had a general and deep impact on the clinical management of
chronic diseases, including respiratory and allergic disorders. At the beginning of the …

The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria

E Kocatürk, A Salman, I Cherrez‐Ojeda, PR Criado… - Allergy, 2020 - Wiley Online Library
Introduction The COVID‐19 pandemic dramatically disrupts health care around the globe.
The impact of the pandemic on chronic urticaria (CU) and its management are largely …

[HTML][HTML] COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals)–A Position Paper of the German …

O Pfaar, L Klimek, E Hamelmann… - Allergologie …, 2021 - ncbi.nlm.nih.gov
Background: After the beginning and during the worldwide pandemic caused by the severe
acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), patients with allergic and …

[HTML][HTML] Anti-IL5 drugs in COVID-19 patients: role of eosinophils in SARS-CoV-2-induced immunopathology

D Pala, M Pistis - Frontiers in Pharmacology, 2021 - frontiersin.org
SARS-CoV-2 infection stimulates a complex activation of the immune system. Eosinophils
belong to the host's defense equipment against respiratory viruses. In the first phase of the …

COVID-19 and its impact on common diseases in the allergy clinics

E Kocatürk, EM Abrams, M Maurer, J Mitri… - The Journal of Allergy …, 2023 - Elsevier
Coronavirus disease 2019 (COVID-19) is a highly contagious viral disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has various effects on …

[HTML][HTML] Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status

TB Casale, AM Gimenez-Arnau, JA Bernstein… - Dermatology and …, 2023 - Springer
Chronic spontaneous urticaria (CSU) is a debilitating inflammatory disorder of the skin,
characterized by a fluctuating natural history, a complex mechanism of action, and a …

[HTML][HTML] Management of allergic diseases during COVID-19 outbreak

A Izquierdo-Domínguez, MJ Rojas-Lechuga… - Current Allergy and …, 2021 - Springer
Abstract Purpose of Review The coronavirus disease 2019 (COVID-19) has challenged
healthcare system capacities and safety for health care workers, reshaping doctor-patient …

[HTML][HTML] Real Life Observational Study of Treatment Success of Monoclonal Antibodies for Refractory Chronic Rhinosinusitis with Nasal Polyps

K Gerstacker, MC Ketterer, TF Jakob… - Journal of Clinical …, 2023 - mdpi.com
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a mainly type-2-driven inflammatory
disease that is often refractory to medical and surgical treatment and characterized by a high …

[HTML][HTML] Biologics for atopic diseases: Indication, side effect management, and new developments

U Jappe, H Beckert, KC Bergmann, A Gülsen… - Allergologie …, 2021 - ncbi.nlm.nih.gov
With the advent of biologicals, more and more therapeutics are available that specifically
address specific switch points in the pathomechanism of immunologically dominated …